Cardiac function of long-responders to dual anti-HER2 antibodies amongst patients with HER2 positive advanced breast cancer

被引：0
|
作者：
Bao, Kelvin K. H. [1 ]
Chan, Jeffrey C. H. [1 ]
Sutanto, Leone [1 ]
Chan, Jocelyn G. [1 ]
Cheung, Ka Man [1 ]
Yiu, Harry H. Y. [1 ]
机构：
[1] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1043
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Stanowicka-Grada, Malwina
    Senkus, Elzbieta
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650
  • [2] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Malwina Stanowicka-Grada
    Elżbieta Senkus
    Current Treatment Options in Oncology, 2023, 24 : 1633 - 1650
  • [3] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [4] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
  • [5] Long-responders to anti-HER2 therapies: A case report and review of the literature
    Cantini, Luca
    Pistelli, Mirco
    Savini, Agnese
    Bastianelli, Lucia
    Della Mora, Arianna
    Merloni, Filippo
    Burattini, Michela
    Berardi, Rossana
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 147 - 152
  • [6] Handling of anti-HER2 antibodies, trastuzumab and pertuzumab, in patients with HER2-positive breast cancer
    Araki, Kazuhiro
    Ito, Yoshinori
    ANNALS OF ONCOLOGY, 2015, 26 : 48 - 48
  • [7] Prediction of HER2 positive breast cancer patients' response to anti-HER2 therapy using mRNA level
    Atallah, N.
    Makhlouf, S.
    Li, X. M.
    Zhangy, Y.
    Rakha, E.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 114 - 114
  • [8] Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer
    Yu, Anthony F.
    Singh, Jasmeet C.
    Wang, Rui
    Liu, Jennifer E.
    Eaton, Anne
    Oeffinger, Kevin C.
    Steingart, Richard M.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGIST, 2017, 22 (06): : 642 - 647
  • [9] Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade
    Batalha, Sofia
    Gomes, Catarina Monteiro
    Brito, Catarina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] The HER2 CISH pharmDx™ Kit in the assessment of breast cancer patients for anti-HER2 treatment
    Foged, Niels T.
    Brugmann, Anja
    Jorgensen, Jan T.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (03) : 233 - 242
12345